Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Gerrit van den Dool to its Board of Directors, as a Non-Executive Director. With more than 25 years’ experience in ... more
Gyros Expands Asian Distribution to Singapore
Gyros AB announced that Bio Laboratories Pte Ltd has become sole distributor for the company’s nanoliter-scale immunoassay platform in Singapore.
“We are very pleased to expand our reach in Asia through this new partnership with Bio Laboratories, which provides a valuable addition to our recently announced collaboration with GE Healthcare for distribution in Japan, China, Taiwan and Hong Kong,” commented Erik Walldén, CEO, Gyros.
- Bio Laboratories
Gyros AB announced the completion of a development program initiated to fulfill the requirements of scientists using the Company’s immunoassay platform in the biopharmaceutical industry. The development program has seen the release of a number of software modules and services to augment th ... more
Gyros® AB announced the signing of an exclusive distribution agreement with SCRUM Inc. Under the terms of the agreement, SCRUM will market, sell and fully support the Gyros product range, within the Japanese biopharmaceutical, contract research and contract manufacturing industries. "We ar ... more
Gyros AB announced that Bio Laboratories Pte Ltd has become sole distributor for the company’s nanoliter-scale immunoassay platform in Singapore. “We are very pleased to expand our reach in Asia through this new partnership with Bio Laboratories, which provides a valuable addition to our re ... more
- Illuminating the contacts
- Routine blood test predicts how long cancer patients will survive
- NovogeneAIT Singapore and the Genome Institute of Singapore forge Public-Private Partnership
- Quick test to detect inflammation in diabetic patients developed
- Water and light 'flow' inspire ultrasensitive optical microfiber coupler sensor